| |
Yun-Hwa Peggy Hsieh, Professor, Department of Nutrition, Food and Exercise Sciences, Florida State University, USA
Mitchell Ho, Head, Antibody Therapy Unit LMB, National Cancer Institute, National Institues of Health, USA
Paul Imbach,Professor, Historical Faculty, University of Basel, Switzerland
Juan Carlos Almagro, Head, Antibody Design Group, Centocor R&D, Inc., USA
Dr. Yan Chen, Senior Vice President, Research, X-BODY BioSciences, USA
Juraj Ivanyi, Professor, Clinical and Diagnostic Sciences Department, Kings College London, UK
Davis Farmer, Chairman, MSM Protein Technologies Inc., USA
Christopher Stewart, Senior Director, Asia-Pacific Business Affairs, MPI Research, USA
Haripada Maity, Senior Scientific Manager, Formulation Development, ImClone Systems, A Wholly-Owned Subsidiary of Eli Lilly and Company, USA
Francesco Dazzi, Professor, Department of Haematology, Imperial College at Hammersmith Hospital, UK
Christopher J. Mann, Global Head of Application Support and Training, Genetix, UK
Hervé Perron, CSO, GeNeuro SA, Switzerland
Lionel Rostaing, Professor, Organ Transplant Unit, Toulouse University Hospital, CHU Rangueil, France
Ahmed Al-Qahtani, President and Founder, A & G Skin Solutions, Inc., USA
Rostaing, Professor, Organ Transplant Unit, Toulouse University Hospital, CHU Rangueil, France
Frank Zhang, CEO, Genscript Corporation, USA
Leodevico (Vic) L. Ilag, Chief Operating Officer, Patrys Ltd, Australia
David Basiji, President, CEO and Founder, Amnis Corporation, USA
Dewey Ryu, Professor, Director, Biochemical Engineering Program, Department of Chemical Engineering and Material Science, University of California, USA
Sarah Fredriksson, CEO, Genovis AB, Sweden
Kathleen Madden Williams, Partner, Edwards Angell Palmer & Dodge LLP, USA
Jianying Dong, Senior Scientist, Oncology Discovery, Biogen Idec, USA
Peter L. Bonate, Director, Clinical Pharmacology, Modeling, & Simulation, GlaxoSmithKline, USA
Thomas P. Greco, Associate Clinical Professor, Yale University; Chairman, Dept of Inflammatory Diseases, St. Mary's Hospital, USA
Chuck Goolsby, Patterson Professor of Pathology, Director of Flow Cytometry, Department of Pathology, Northwestern University Medical School, USA
Gowrisankar Rajam, Team Leader, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, USA
Dr. John D. Catravas, Professor, Director, Vascular Biology Center, Medical College of Georgia, USA
Gilad Gor, President, ORRA Group, LLC, USA
Ferdinand Bach, CEO, Oncoscience AG, Germany
Scott Knell, Enterprise Architect, Head, Information Technology Strategy, MedImmune, Inc., USA
George T. Spencer-Green, Medical Director, Vertex Pharmaceuticals, Inc., USA
Jijie Gu, Principal Scientist, Department of Biologics, Abbott Bioresearch Center, USA
Tariq Ghayur, Senior Principal Scientist, Abbott Bioresearch Center, USA
Teodor Aastrup, CEO, Attana AB, Sweden
Nabeela Rasheed, Shareholder, McAndrews, Held & Malloy, Ltd., USA
Wenle Xia, Director, Oncology Research Laboratory, Duke University Medical Center, USA
|
